In collaboration with multiple academic institutions in the United States and in Europe, this hybrid (in-person and via zoom) course will review the management of drug-resistant epilepsy (DRE). It will include principles and cased based scenarios of rational pharmacotherapy with traditional (1st and 2nd generation) and novel (3rd generation) antiseizure medications, non-pharmacological treatments (ketogenic diet) and workshops on various neuromodulation modalities. Empasis will be given to the basic tenets of presurgical evaluation for destructive (resections, ablations) or disconnective (corpus callosotomy, hemispherectomy) surgery, as well as to special populations (pediatric, pregnant women, elderly).
📅 Dates
- Start: Tuesday, 16 June 2026
- End: Friday, 19 June 2026
There will be a welcome dinner on Tues 16 June 2026 evening and an optional excursion to the island of Spinalonga on Sat 20 June morning.
Application procedure:
Online application (by email to ioannis.karakis@uoc.gr and yianniskarakis@yahoo.com)
Deadline: June 10th, 2026
More Information of the Program
Educators:
Ioannis Karakis, MD, University of Crete, Heraklion
Angelica Rivera-Cruz, MD, University of South Florida, Tampa, FL
Vasileios Kokkinos, PhD, Rutgers University, New Brunswick, NJ
Andreas Alexopoulos, MD, Cleveland Clinic, Cleveland, OH
Edward Faught, MD, Emory University, Atlanta, GA
Katie Bullinger, MD, Emory University, Atlanta, GA
Efrosini Papadaki, MD, University of Crete, Heraklion
Valeria Moncayo, MD, Emory University, Atlanta, GA
Stefan Schuele, MD, Northwestern University, Chicago, IL
Sotirios Mitropanopoulos, MD, Mayo Clinic, Scottsdale, AZ
Abed Alwaki, MD, UTHealth Houston Neurosciences Center, Houston, TX
Daniel Drane, PhD, Emory University, Atlanta, GA
Nikolaos Haliasos, MD, National and Kapodistrian University, Athens
Pelagia Vorgia, MD, University of Crete, Herakion
Vasileios Kimiskidis, MD, Aristotle University, Thessaloniki
Christos Papadelis, PhD, University of Texas, Fort Worth, TX
PHOTOS FROM PREVIOUS YEARS
